The Course of COVID-19 in Four Patients with HIV During the Pandemic

被引:4
作者
Turken, Melda [1 ]
Altan, Hividar [1 ]
Atalay, Sabri [1 ]
Kose, Sukran [1 ]
机构
[1] Univ Hlth Sci, Izmir Tepecik Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Yenisehir, Izmir, Konak, Turkey
关键词
CD4; coagulopathy; COVID-19; HIV; pandemic; retinal degenaration; SARS-CoV-2;
D O I
10.2174/1570162X18666201201093540
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: The clinical spectrum of SARS-CoV-2 infection may vary from simple colds to a severe acute respiratory syndrome, metabolic acidosis, septic shock, and multiple organ failure. Current evidence indicates that the risk of severe illness increases with age, in the male sex, and with certain chronic medical problems. Many people living with HIV have other conditions that increase their risk. Case presentation: In the first 3 months of the pandemic, four patients with HIV were hospitalized in our clinic because of COVID-19. The disease severity was mild in two patients with normal CD4+ T count. However, one patient with a low CD4+T count died and the other developed retinal detachment one month after discharge. The deceased patient had a malignancy. Conclusion: In this study, the effect of the immunological status of the patients on the course of COVID-19 and the developing vascular complications was evaluated in 4 patients with HIV.
引用
收藏
页码:286 / 291
页数:6
相关论文
共 43 条
[21]   COVID-19: progression of disease and intravascular coagulation - present status and future perspectives [J].
Harenberg, Job ;
Favaloro, Emmanuel .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (07) :1029-1036
[22]   Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets [J].
He, ZP ;
Zhao, CH ;
Dong, QM ;
Zhuang, H ;
Song, SJ ;
Peng, G ;
Dwyer, DE .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2005, 9 (06) :323-330
[23]   Clinical Outcomes and Immunologic Characteristics of Coronavirus Disease 2019 in People With Human Immunodeficiency Virus [J].
Ho, Hsi-en ;
Peluso, Michael J. ;
Margus, Colton ;
Lopes, Joao Pedro Matias ;
He, Chen ;
Gaisa, Michael M. ;
Osorio, Georgina ;
Aberg, Judith A. ;
Mullen, Michael P. .
JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (03) :403-408
[24]  
Horby P, 2020, medRxiv, DOI [10.1101/2020.07.15.20151852, 10.1101/2020.07.15.20151852v1, DOI 10.1101/2020.07.15.20151852V1, 10.1101/2020.07.15.20151852]
[25]  
Huang CL, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30211-7, 10.1016/S0140-6736(20)30183-5]
[26]   Treating COVID-19 with Chloroquine [J].
Huang, Mingxing ;
Tang, Tiantian ;
Pang, Pengfei ;
Li, Man ;
Ma, Ruolan ;
Lu, Jiahui ;
Shu, Jingxian ;
You, Yingying ;
Chen, Binghui ;
Liang, Jiabi ;
Hong, Zhongsi ;
Chen, Huili ;
Kong, Ling ;
Qin, Dajiang ;
Pei, Duanqing ;
Xia, Jinyu ;
Jiang, Shanping ;
Shan, Hong .
JOURNAL OF MOLECULAR CELL BIOLOGY, 2020, 12 (04) :322-325
[27]  
Ivashchenko AA, 2020, CLIN INFECT DIS
[28]   Ebola virus dynamics in mice treated with favipiravir [J].
Madelain, Vincent ;
Oestereich, Lisa ;
Graw, Frederik ;
Thi Huyen Tram Nguyen ;
de Lamballerie, Xavier ;
Mentre, France ;
Guenther, Stephan ;
Guedj, Jeremie .
ANTIVIRAL RESEARCH, 2015, 123 :70-77
[29]   Retinal findings in patients with COVID-19 [J].
Marinho, Paula M. ;
Marcos, Allexya A. A. ;
Romano, Andre C. ;
Nascimento, Heloisa ;
Belfort, Rubens, Jr. .
LANCET, 2020, 395 (10237) :1610-1610
[30]  
Ministry of Health Turkey, 2020, GUID COVID 19 AD PAT